山東鋼鐵(600022.SH):董事、總經理張潤生逝世
格隆匯6月27日丨山東鋼鐵(600022.SH)公佈,董事、總經理張潤生先生因突發疾病經搶救無效,於2025年6月26日逝世。張潤生先生在擔任公司董事、總經理期間,兢兢業業、勤勉盡職、恪盡職守,認真履行了作爲公司董事、高級管理人員應盡的職責和義務,公司董事會對張潤生先生爲公司發展所做出的突出貢獻和努力表示衷心感謝!公司董事、監事、高級管理人員及全體員工對張潤生先生的逝世表示沉痛哀悼,並向其家屬致以深切慰問。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.